| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.085 | 0.005 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.005 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.006 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.16 | 0.007 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.093 | 0.007 |